Filing Flows › Geron (GERN) › Recalls, complaints & regulation
Geron (GERN): clinical trials
Geron (GERN) beyond its filings: 3 active clinical trials.
Geron's latest quarter
Geron, Q3 2026: revenue $60.2M (+27% year over year), operating margin 9.6%, net earnings $1.4M, operating cash flow $10.3M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Geron have?
3 active studies on ClinicalTrials.gov, 2 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.